SCHEDULE 13D/A

CASI PHARMACEUTICALS INC

Ordinary Shares · CUSIP: G1933S101

Event date: 2026-01-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• WEI-WU HE, Ph.D.Reported CIK 0001542073

  Shares: 8,965,535.00 · Class: 34.8%

• HUIYING MEMORIAL FOUNDATION

  Shares: 637,644.00 · Class: 3.1%

• EMERGING TECHNOLOGY PARTNERS, LLC

  Shares: 1,097,341.00 · Class: 5.3%

• ETP Global Fund L.P.

  Shares: 753,234.00 · Class: 3.7%

• ETP BIOHEALTH III FUND, L.P.

  Shares: 300,000.00 · Class: 1.5%

• HE Family GRAT

  Shares: 100,000.00 · Class: 0.5%

• ETP Global Fund III L.P.

  Shares: 5,000,000.00 · Class: 19.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.